drugset / Trial / NCT00586846
Phase II Study of Chemotherapy and Pamidronate for the Treatment of Newly Diagnosed Osteosarcoma
NaSingle-groupOpen-labelTreatment
Summary
This study is designed to test the safety and feasibility of the simultaneous administration of a biphosphonate with chemotherapy for the treatment of osteosarcoma in newly diagnosed patients.
Timeline
- Start
- 2003-07
- Primary completion
- 2009-02
- Completion
- 2009-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Cisplatin | Other / unclassified | 120 mg/m2 | — |
| Subject | Doxorubicin | Other / unclassified | 75 mg/m2 | — |
| Subject | Methotrexate | Small molecule | 12 g | — |